Literature DB >> 2923479

Production of interferon in respiratory syncytial virus bronchiolitis.

D Isaacs1.   

Abstract

Production of interferon alfa in vitro was significantly reduced during acute respiratory syncytial virus bronchiolitis but subsequently returned to normal. Nasopharyngeal and endotracheal interferon alfa were detected intermittently and in low concentrations. The degree of impairment of in vitro production and poor in vivo production of interferon alfa suggest the need for a therapeutic trial of nebulised or systemic interferon in acute bronchiolitis.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2923479      PMCID： PMC1791825          DOI： 10.1136/adc.64.1.92

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  16 in total

1.  Interferon production in children with respiratory syncytial, influenza, and parainfluenza virus infections.

Authors:  C B Hall; R G Douglas; R L Simons; J M Geiman
Journal:  J Pediatr       Date:  1978-07       Impact factor: 4.406

2.  Prevention of natural colds by contact prophylaxis with intranasal alpha 2-interferon.

Authors:  F G Hayden; J K Albrecht; D L Kaiser; J M Gwaltney
Journal:  N Engl J Med       Date:  1986-01-09       Impact factor: 91.245

3.  The definition of acute respiratory illnesses in children.

Authors:  S D Court
Journal:  Postgrad Med J       Date:  1973-11       Impact factor: 2.401

4.  Experimental respiratory syncytial virus infection of adults. Possible mechanisms of resistance to infection and illness.

Authors:  J Mills; J E Van Kirk; P F Wright; R M Chanock
Journal:  J Immunol       Date:  1971-07       Impact factor: 5.422

5.  The role of the interferon system in respiratory syncytial virus infections.

Authors:  J M Moehring; B R Forsyth
Journal:  Proc Soc Exp Biol Med       Date:  1971-12

6.  Respiratory syncytial virus infections within families.

Authors:  C B Hall; J M Geiman; R Biggar; D I Kotok; P M Hogan; G R Douglas
Journal:  N Engl J Med       Date:  1976-02-19       Impact factor: 91.245

7.  Prophylactic efficacy of intranasal alpha 2-interferon against rhinovirus infections in the family setting.

Authors:  R M Douglas; B W Moore; H B Miles; L M Davies; N M Graham; P Ryan; D A Worswick; J K Albrecht
Journal:  N Engl J Med       Date:  1986-01-09       Impact factor: 91.245

8.  Mammary immunity in mothers of infants with respiratory syncytial virus infection.

Authors:  N Nandapalan; C Taylor; R Scott; G L Toms
Journal:  J Med Virol       Date:  1987-07       Impact factor: 2.327

9.  Interferon in nasal secretions from infants with viral respiratory tract infections.

Authors:  K McIntosh
Journal:  J Pediatr       Date:  1978-07       Impact factor: 4.406

10.  Cell-mediated cytotoxic response to respiratory syncytial virus in infants with bronchiolitis.

Authors:  D Isaacs; C R Bangham; A J McMichael
Journal:  Lancet       Date:  1987-10-03       Impact factor: 79.321
View more
  18 in total

Review 1.  The respiratory syncitial virus and its role in acute bronchiolitis.

Authors:  M L Everard; A D Milner
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

2.  Association of fever and severe clinical course in bronchiolitis.

Authors:  A S El-Radhi; W Barry; S Patel
Journal:  Arch Dis Child       Date:  1999-09       Impact factor: 3.791

Review 3.  Why do viruses make infants wheeze?

Authors:  I M Balfour-Lynn
Journal:  Arch Dis Child       Date:  1996-03       Impact factor: 3.791

Review 4.  Immunity to viruses.

Authors:  D Isaacs
Journal:  Arch Dis Child       Date:  1989-12       Impact factor: 3.791

5.  Treatment of respiratory syncytial virus infection with recombinant interferon alfa-2a.

Authors:  R Y Sung; J Yin; S J Oppenheimer; J S Tam; J Lau
Journal:  Arch Dis Child       Date:  1993-10       Impact factor: 3.791

6.  Depletion of TAX1BP1 Amplifies Innate Immune Responses during Respiratory Syncytial Virus Infection.

Authors:  Delphyne Descamps; Andressa Peres de Oliveira; Lorène Gonnin; Sarah Madrières; Jenna Fix; Carole Drajac; Quentin Marquant; Edwige Bouguyon; Vincent Pietralunga; Hidekatsu Iha; Armando Morais Ventura; Frédéric Tangy; Pierre-Olivier Vidalain; Jean-François Eléouët; Marie Galloux
Journal:  J Virol       Date:  2021-08-25       Impact factor: 5.103

7. 

Authors:  François Freymuth; Geneviève Eugène; Jacques Brouard; Astrid Vabret; Joëlle Petitjean; Françoise Bonnin
Journal:  Ann Inst Pasteur Actual       Date:  2000-04-05

8.  Tryptase and IgE concentrations in the respiratory tract of infants with acute bronchiolitis.

Authors:  M L Everard; G Fox; A F Walls; D Quint; R Fifield; C Walters; A Swarbrick; A D Milner
Journal:  Arch Dis Child       Date:  1995-01       Impact factor: 3.791

9.  A genetic model of differential susceptibility to human respiratory syncytial virus (RSV) infection.

Authors:  Jonathan M Ciencewicki; Xuting Wang; Jacqui Marzec; M Elina Serra; Douglas A Bell; Fernando P Polack; Steven R Kleeberger
Journal:  FASEB J       Date:  2014-01-13       Impact factor: 5.191

10.  Induction of type I interferons and interferon-inducible Mx genes during respiratory syncytial virus infection and reinfection in cotton rats.

Authors:  Lioubov M Pletneva; Otto Haller; David D Porter; Gregory A Prince; Jorge C G Blanco
Journal:  J Gen Virol       Date:  2008-01       Impact factor: 3.891
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.